- DocumentQ2R2-Q14_EWG_Concept_Paper.pdfuploaded byIsmail
- DocumentRevised_Q3D(R2)_EWG_WorkPlan_2020_0430.pdfuploaded byIsmail
- DocumentQ3D-R1EWG_Document_Step4_Guideline_2019_0322.pdfuploaded byIsmail
- DocumentQ3D(R2) Concept Paper_1.pdfuploaded byIsmail
- DocumentQ3D Concept Paper.pdfuploaded byIsmail
- DocumentQ3D Training Business Plan.pdfuploaded byIsmail
- DocumentQ3C-R8_Step2_Presentation_2020_0326.pdfuploaded byIsmail
- DocumentQ3D Training Concept Paper.pdfuploaded byIsmail
- DocumentQ3D Business Plan.pdfuploaded byIsmail
- DocumentQ3C-R6_CoverStatement_2019_0722_0.pdfuploaded byIsmail
- DocumentQ3C-R6_Guideline_ErrorCorrection_2019_0410_0.pdfuploaded byIsmail
- DocumentQ3C_R6_Step4_Presentation_0.pdfuploaded byIsmail
- DocumentQ3B(R2) Guideline.pdfuploaded byIsmail
- DocumentQ3A(R2) Guideline.pdfuploaded byIsmail
- DocumentQ3B(R2) Concept Paper.pdfuploaded byIsmail
- DocumentRevised_Q2(R2)-Q14_EWG_WorkPlan_2020_0430.pdfuploaded byIsmail
- DocumentQ2R2-Q14_EWG_Concept_Paper.pdfuploaded byIsmail
- DocumentQ2R2-Q14_EWG_Business_Plan.pdfuploaded byIsmail
- DocumentQ2(R1) Guideline.pdfuploaded byIsmail
- Documentactive_clreleased_hypochlorous_acid_pt1_opinion.pdfuploaded byIsmail
- Documentactive_cl_released-hypochlorous-acid_pt5_opinion_en.pdfuploaded byIsmail
- Documentactive_clreleased_hypochlorous_acid_pt4_opinion_en (1).pdfuploaded byIsmail
- Documentactive_cl_released-hypochlorous_acid_pt3_opinion_en.pdfuploaded byIsmail
- Documentactive_cl_released_hypochlorous_acid_pt2_opinion_en.pdfuploaded byIsmail
- DocumentWHO - GUIDELINE ON DATA INTEGRITY QAS19_819_data_integrity.pdfuploaded byIsmail
- DocumentWHO - QAS19_791_Rev1_Good_Chromatography_Practices.pdfuploaded byIsmail
- DocumentEDQM - Pharmaceutical Reference Standards Regulatory Aspects.pdfuploaded byIsmail
- DocumentCleaning Validation Guidelines.pdfuploaded byIsmail
- DocumentCHLORINE_EFFICACYuploaded byIsmail
- DocumentWHO guidelines for sampling of pharmaceutical.pdfuploaded byIsmail
- DocumentRisk analysis and statistical sampling in audit - Methodology _ Comptroller and Auditor General of Indiauploaded byIsmail
- DocumentThe Application of Science- and Risk-Based Concepts to Drug Substance Stability Strategiesuploaded byIsmail
- DocumentAuditing the quality system for data integrity.pptxuploaded byIsmail
- DocumentA - PDA - Preventing, Detecting, and Solutions.pdfuploaded byIsmail
- Document01_Introduction_to_the_new_paradigm_JLR (1).pptuploaded byIsmail
- DocumentQ1B Guideline.pdfuploaded byIsmail
- DocumentQ1C Guideline.pdfuploaded byIsmail
- DocumentQ1D Guideline.pdfuploaded byIsmail
- DocumentQ3B(R2) Concept Paper.pdfuploaded byIsmail
- DocumentQ3D-R1EWG_Document_Step4_Guideline_2019_0322.pdfuploaded byIsmail
- DocumentQ1E Presentation.pdfuploaded byIsmail
- DocumentQ1D Guideline.pdfuploaded byIsmail
- DocumentQ1C Guideline.pdfuploaded byIsmail
- DocumentQ1B Guideline.pdfuploaded byIsmail